We are live on ! Find out more
Group One Trading

Group One Trading Portfolio holdings

AUM $52.2B
1-Year Est. Return 104.56%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$7.15B
AUM Growth
+$778M
Cap. Flow
+$799M
Cap. Flow %
11.18%
Top 10 Hldgs %
9.56%
Holding
5,720
New
998
Increased
1,852
Reduced
1,702
Closed
889

Sector Composition

Rank Sector Weight
1 Healthcare 3.37%
2 Technology 1.88%
3 Consumer Discretionary 1.68%
4 Energy 1.47%
5 Financials 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROX icon
2526
CALL
Tronox
TROX
$1.04B
$168K ﹤0.01%
11,500
+2,500
+28% +$47.1K
CTXS
2527
PUT
DELISTED
Citrix Systems Inc
CTXS
$168K ﹤0.01%
+3,014
New +$160K
DYN
2528
DELISTED
Dynegy, Inc.
DYN
$168K ﹤0.01%
+5,731
New +$186K
MACK
2529
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$168K ﹤0.01%
+1,729
New +$165K
CKSW
2530
CALL
DELISTED
CLICKSOFTWARE TECH LTD
CKSW
$168K ﹤0.01%
13,400
+12,700
+1,814% +$146K
KNDI
2531
Kandi Technologies Group
KNDI
$65.5M
$167K ﹤0.01%
18,498
-38,751
-68% -$418K
NVRO
2532
PUT
DELISTED
NEVRO CORP.
NVRO
$167K ﹤0.01%
+3,100
New +$158K
IL
2533
PUT
DELISTED
IntraLinks Holdings Inc.
IL
$167K ﹤0.01%
14,000
-2,700
-16% -$28.6K
MSO
2534
DELISTED
MARTHA STEWART LIVING OMNIMEDIA INC
MSO
$167K ﹤0.01%
+26,698
New +$151K
LJPC
2535
CALL
DELISTED
La Jolla Pharmaceutical Company
LJPC
$167K ﹤0.01%
6,800
-1,400
-17% -$28.8K
ARWR icon
2536
Arrowhead Research
ARWR
$12.4B
$166K ﹤0.01%
+23,208
New +$159K
TRIB
2537
PUT
Trinity Biotech
TRIB
$8.39M
$166K ﹤0.01%
+61
New +$158K
SAGE
2538
DELISTED
Sage Therapeutics
SAGE
$165K ﹤0.01%
+2,255
New +$145K
CLIR icon
2539
ClearSign Technologies
CLIR
$25.5M
$164K ﹤0.01%
3,026
+3,016
+30,160% +$162K
EC icon
2540
PUT
Ecopetrol
EC
$34.5B
$164K ﹤0.01%
12,400
-3,700
-23% -$56.7K
FCX icon
2541
Freeport-McMoran
FCX
$97.5B
$164K ﹤0.01%
8,809
-112,906
-93% -$2.33M
GURE
2542
CALL
Gulf Resources
GURE
$4.85M
$164K ﹤0.01%
1,588
+1,570
+8,722% +$184K
JAZZ icon
2543
Jazz Pharmaceuticals
JAZZ
$16.7B
$164K ﹤0.01%
930
+225
+32% +$40.4K
MRC
2544
CALL
DELISTED
MRC Global
MRC
$164K ﹤0.01%
10,600
-8,800
-45% -$133K
RYAM icon
2545
CALL
Rayonier Advanced Materials
RYAM
$610M
$164K ﹤0.01%
10,100
+100
+1% +$1.65K
SBS icon
2546
CALL
Sabesp
SBS
$18.7B
$164K ﹤0.01%
163,462
+155,212
+1,881% +$175K
SEEL
2547
CALL
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
NTUS
2548
DELISTED
Natus Medical Inc
NTUS
$164K ﹤0.01%
3,848
+2,548
+196% +$102K
GLOG
2549
DELISTED
GASLOG LTD
GLOG
$164K ﹤0.01%
8,206
-13,583
-62% -$287K
CSC
2550
PUT
DELISTED
Computer Sciences
CSC
$164K ﹤0.01%
5,933
+4,035
+213% +$113K

Similar funds

Group One Trading's Q2 2015 Portfolio in Review

As of Q2 2015, Group One Trading held 5,720 positions worth $7.15B, up 12% from $6.37B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Group One Trading deployed $799M of net new capital in Q2 2015, opening 998 new positions and adding to 1,852 existing holdings. Its largest new stake was Viatris: 122,934 shares worth $8.34M.

By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, up from 2.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Allergan plc, an estimated $21.2M trimmed.

  • Group One Trading's largest Q2 2015 buy was Viatris: 122,934 shares worth $8.34M.
  • Group One Trading added most to Williams Companies in Q2 2015, an estimated $22.3M increase.
  • Group One Trading's biggest Q2 2015 reduction was Allergan plc, cutting an estimated $21.2M.
  • Group One Trading fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $89.2M.
  • Group One Trading's ten largest holdings make up 9.6% of its $7.15B portfolio in Q2 2015.
  • Group One Trading opened 998 new positions and closed 889 in Q2 2015.
  • Group One Trading's portfolio value rose 12% quarter-over-quarter to $7.15B.

Based on Group One Trading's 13F filing for Q2 2015, filed 11 Aug 2015.